Discovery of 3-(1<i>H</i>-Indol-3-yl)-4-[2-(4-methylpiperazin-1-yl)quinazolin-4-yl]pyrrole-2,5-dione (AEB071), a Potent and Selective Inhibitor of Protein Kinase C Isotypes
Jürgen Wagner(Vogtland-Klinik), Sylvain Cottens, Wilhelm Stark(Novartis (Switzerland)), Peter Matt(Novartis (Switzerland)), Sandra W. Cowan‐Jacob(Novartis (Switzerland)), Gabriele Rummel(Novartis (Switzerland)), Richard Sedrani(Novartis (Switzerland)), Christian Beerli(Novartis (Switzerland)), Gisbert Weckbecker(Novartis (Switzerland)), André Strauss(Novartis (Switzerland)), Nigel G. Cooke(Novartis (Switzerland)), Jean-Pierre Evenou(Novartis (Switzerland)), Claus Ehrhardt(Novartis (Switzerland)), Gerhard Zenke, Rainer Albert(Novartis (Switzerland)), Martin Geiser(Novartis (Switzerland))
Cited by 135
Related Papers
Efficient Aldolase Catalytic Antibodies That Use the Enamine Mechanism of Natural Enzymes
|Science|1995|458
The Potent Protein Kinase C-Selective Inhibitor AEB071 (Sotrastaurin) Represents a New Class of Immunosuppressive Agents Affecting Early T-Cell Activation
|Journal of Pharmacology and Experimental Therapeutics|2009|160
Discovery, Preclinical Characterization, and Early Clinical Activity of JDQ443, a Structurally Novel, Potent, and Selective Covalent Oral Inhibitor of KRASG12C
|Cancer Discovery|2022|134
Sanglifehrin−Cyclophilin Interaction: Degradation Work, Synthetic Macrocyclic Analogues, X-ray Crystal Structure, and Binding Data
|Journal of the American Chemical Society|2003|113
K<sub>2</sub>[Al<sub>12</sub><i>i</i>Bu<sub>12</sub>], a Compound with Al<sub>12</sub> Icosahedra
|Angewandte Chemie International Edition in English|1991|101